Skip to main content
. 2025 Feb 19;10(2):e017268. doi: 10.1136/bmjgh-2024-017268

Table 2. Estimated potential number of mpox cases in South Africa among MSMLAHIV, MSMLHIV and in total under four scenarios with corresponding parameter assumptions.

Scenario: Central Sensitivity analyses
OR of LHIV among mpox cases vs all MSM: 9.2 (8.0–10.6) 9.2 (8.0–10.6) 1 1
Definition of AHIV: CD4<200/mm3 CD4<100/mm3 CD4<200/mm3 CD4<100/mm3
Observed DAHIV 3 3 3 3
Assumed PDAHIVCAHIV 15.0%(10.2%–20.6%) 27.1%(18.1%–36.8%) 15.0%(10.2%–20.6%) 27.1%(18.1%–36.8%)
Estimated CAHIV 21 (15–29) 11 (8–17) 21 (15–29) 11 (8–17)
Observed CAHIV 15 15 15 15
Assumed P(CAHIV|CHIV) 6.6% 3.3% 6.6% 3.3%
Estimated CHIV 313(227–444) 458(455–503) 313(227–444) 458(455–503)
Assumed P(CHIV|C) 79.1%(75.0%–82.9%) 79.1%(75.0%–82.9%) 29.4%(25.5%–33.5%) 29.4%(25.5%–33.5%)
Estimated C 395(287–562) 579(549–640) 1068(750–1543) 1565(1361–1832)
Estimated P(D|C) 0.78%(0.53%–1.05%) 0.52%(0.47%–0.55%) 0.29%(0.19%–0.40%) 0.19%(0.16%–0.22%)
Estimated cases detected 5.7%(3.9%–7.7%) 3.8%(3.4%–4.0%) 2.1%(1.4%–2.9%) 1.4%(1.2%–1.6%)

Results are presented as mean (95% CI) where applicable.

AHIVadvanced HIVLHIVliving with HIVMSMmen-who-have-sex-with-menMSMLAHIVMSM living with advanced HIVMSMLHIVMSM living with HIV